Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Equity Ratio
57.35%
Quarterly · Period ending:
LCTX Equity Ratio
Latest reported57.35%period ending
Latest reported57.35%period ending
LCTX Quarterly Equity Ratio (94.23% → 57.35%)
Latest values, visible window
High-resolution chart · PNG
LCTX equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 57.3489% | |
| 49.1861% | |
| 39.5696% | |
| 24.5875% | |
| 53.288% | |
| 70.7167% | |
| 69.2302% | |
| 68.5198% | |
| 66.4384% | |
| 66.7404% | |
| 62.7793% | |
| 64.1687% | |
| 65.0625% | |
| 62.2322% | |
| 59.3051% | |
| 60.1976% | |
| 60.9519% | |
| 59.8858% | |
| 52.8351% | |
| 91.9977% | |
| 92.5486% | |
| 91.9846% | |
| 89.1152% | |
| 88.5304% | |
| 88.7241% | |
| 89.5838% | |
| 90.023% | |
| 88.1025% | |
| 87.9334% | |
| 88.6395% | |
| 92.3077% | |
| 97.1887% | |
| 89.96% | |
| 90.5548% | |
| 93.8814% | |
| 89.3716% | |
| 91.0899% | |
| 91.3048% | |
| 82.7147% | |
| 80.9025% | |
| 82.1868% | |
| 13.5457% | |
| 28.408% | |
| 16.97% | |
| 21.3277% | |
| 37.6601% | |
| 48.6723% | |
| 19.7313% | |
| 27.1459% | |
| 33.2062% | |
| 25.638% | |
| 41.9403% | |
| 52.4288% | |
| 44.8897% | |
| 32.2185% | |
| 51.5357% | |
| 60.3849% | |
| 62.0852% | |
| 62.5053% | |
| 66.0923% | |
| 67.6119% | |
| 71.8173% | |
| 71.6544% | |
| 85.1406% | |
| 81.2999% | |
| 50.7097% | |
| 52.4556% | |
| 44.7482% | |
| -14.3129% | |
| -291.2372% | |
| -419.7967% | |
| -469.9322% | |
| -643.3234% | |
| -596.3027% | |
| -1,739.7797% | |
| -4,585.3898% | |
| -1,314.0493% | |
| -647.088% | |
| -286.7334% | |
| -184.7668% | |
| -107.3835% | |
| -35.4312% | |
| -10.0359% | |
| -195.7709% | |
| -101.5147% | |
| -38.5928% | |
| 22.6585% | |
| 53.8063% | |
| 61.697% | |
| 74.6228% | |
| -226.8268% | |
| -140.4023% | |
| -272.1815% | |
| -124.4348% | |
| -78.2809% | |
| -18.1993% | |
| -212.7538% | |
| -58.9216% | |
| -5.1043% | |
| -44.8244% |